Cintas Valuation
Is CTAS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CTAS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CTAS * (MX$11425.35) is trading above our estimate of fair value (MX$6830.81)
Significantly Below Fair Value: CTAS * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CTAS *?
Other financial metrics that can be useful for relative valuation.
What is CTAS *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$70.15b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.7x |
Enterprise Value/EBITDA | 31.6x |
PEG Ratio | 5.5x |
Price to Earnings Ratio vs Peers
How does CTAS *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 31.8x | ||
CPRT Copart | 37.7x | 9.7% | US$52.5b |
BXB Brambles | 18.8x | 8.3% | AU$19.9b |
RBA RB Global | 45x | 18.0% | US$13.8b |
SPIE SPIE | 25.9x | 16.1% | €6.2b |
CTAS * Cintas | 46.9x | 8.6% | Mex$70.1b |
Price-To-Earnings vs Peers: CTAS * is expensive based on its Price-To-Earnings Ratio (46.9x) compared to the peer average (31.8x).
Price to Earnings Ratio vs Industry
How does CTAS *'s PE Ratio compare vs other companies in the Global Commercial Services Industry?
Price-To-Earnings vs Industry: CTAS * is expensive based on its Price-To-Earnings Ratio (46.9x) compared to the Global Commercial Services industry average (17.9x).
Price to Earnings Ratio vs Fair Ratio
What is CTAS *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 46.9x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CTAS *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$11,425.35 | Mex$11,500.97 +0.7% | 13.2% | Mex$13,116.21 | Mex$7,969.34 | n/a | 15 |
May ’25 | n/a | Mex$11,413.30 0% | 13.2% | Mex$13,117.79 | Mex$7,970.30 | n/a | 16 |
Apr ’25 | n/a | Mex$11,367.57 0% | 13.7% | Mex$13,089.04 | Mex$7,621.46 | n/a | 16 |
Mar ’25 | n/a | Mex$10,562.55 0% | 10.5% | Mex$11,968.74 | Mex$7,865.17 | n/a | 17 |
Feb ’25 | n/a | Mex$10,557.07 0% | 10.1% | Mex$12,042.80 | Mex$7,913.84 | n/a | 17 |
Jan ’25 | n/a | Mex$10,294.34 0% | 11.0% | Mex$11,881.94 | Mex$7,808.13 | n/a | 17 |
Dec ’24 | n/a | Mex$9,239.34 0% | 11.1% | Mex$10,834.11 | Mex$7,050.77 | n/a | 17 |
Nov ’24 | n/a | Mex$9,399.08 0% | 8.6% | Mex$10,651.20 | Mex$7,376.68 | n/a | 16 |
Oct ’24 | n/a | Mex$9,271.13 0% | 8.6% | Mex$10,468.63 | Mex$7,250.24 | n/a | 16 |
Sep ’24 | n/a | Mex$8,776.15 0% | 8.4% | Mex$9,734.23 | Mex$6,771.64 | n/a | 16 |
Aug ’24 | n/a | Mex$8,776.15 0% | 8.4% | Mex$9,734.23 | Mex$6,771.64 | n/a | 16 |
Jul ’24 | n/a | Mex$8,747.44 0% | 9.0% | Mex$9,654.37 | Mex$6,740.51 | n/a | 15 |
Jun ’24 | n/a | Mex$8,747.44 0% | 9.0% | Mex$9,654.37 | Mex$6,740.51 | n/a | 15 |
May ’24 | n/a | Mex$8,889.78 0% | 9.1% | Mex$9,852.99 | Mex$6,850.34 | n/a | 14 |
Apr ’24 | n/a | Mex$8,767.95 0% | 12.8% | Mex$9,914.74 | Mex$5,409.69 | n/a | 13 |
Mar ’24 | n/a | Mex$9,074.12 0% | 13.4% | Mex$10,036.77 | Mex$5,662.25 | n/a | 12 |
Feb ’24 | Mex$8,782.59 | Mex$8,937.21 +1.8% | 13.8% | Mex$9,897.38 | Mex$5,452.90 | n/a | 12 |
Jan ’24 | n/a | Mex$9,352.55 0% | 13.7% | Mex$10,368.18 | Mex$5,712.28 | n/a | 12 |
Dec ’23 | n/a | Mex$8,451.44 0% | 13.3% | Mex$10,149.46 | Mex$5,645.03 | n/a | 12 |
Nov ’23 | Mex$8,230.00 | Mex$8,588.13 +4.4% | 12.1% | Mex$9,865.30 | Mex$5,819.53 | n/a | 12 |
Oct ’23 | Mex$8,230.00 | Mex$8,692.97 +5.6% | 12.7% | Mex$9,985.73 | Mex$5,729.19 | n/a | 12 |
Sep ’23 | Mex$8,230.00 | Mex$8,540.77 +3.8% | 13.1% | Mex$9,832.92 | Mex$5,652.93 | n/a | 12 |
Aug ’23 | Mex$8,230.00 | Mex$8,719.02 +5.9% | 12.7% | Mex$10,146.51 | Mex$5,833.22 | n/a | 12 |
Jul ’23 | Mex$8,230.00 | Mex$8,812.78 +7.1% | 14.6% | Mex$10,252.11 | Mex$5,611.89 | n/a | 12 |
Jun ’23 | Mex$8,230.00 | Mex$8,812.78 +7.1% | 14.6% | Mex$10,252.11 | Mex$5,611.89 | n/a | 12 |
May ’23 | n/a | Mex$8,892.89 0% | 13.8% | Mex$10,283.60 | Mex$5,629.12 | n/a | 12 |
Analyst Forecast: Target price is less than 20% higher than the current share price.